
Keiretsu Capital
North America, Washington, United States, Seattle
Description
Keiretsu Capital provides access to proprietary deal flow to its investors.
Investor Profile
Keiretsu Capital has made 278 investments, with 1 in the past 12 months and 1% as lead.
Stage Focus
- Series A (27%)
- Convertible Note (23%)
- Seed (20%)
- Series Unknown (13%)
- Series B (10%)
- Series C (2%)
- Post Ipo Equity (1%)
- Angel (1%)
- Private Equity (1%)
- Grant (1%)
Country Focus
- United States (92%)
- Canada (5%)
- United Kingdom (1%)
- Israel (1%)
- India (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Software
- Therapeutics
- Information Technology
- Saas
- Manufacturing
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.